417 related articles for article (PubMed ID: 7692009)
1. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
[TBL] [Abstract][Full Text] [Related]
2. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Brouillet E; Hyman BT; Jenkins BG; Henshaw DR; Schulz JB; Sodhi P; Rosen BR; Beal MF
Exp Neurol; 1994 Oct; 129(2):175-82. PubMed ID: 7525331
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.
Beal MF; Brouillet E; Jenkins B; Henshaw R; Rosen B; Hyman BT
J Neurochem; 1993 Sep; 61(3):1147-50. PubMed ID: 7689641
[TBL] [Abstract][Full Text] [Related]
4. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Chen Q; Reiner A
Exp Neurol; 1997 Aug; 146(2):444-57. PubMed ID: 9270055
[TBL] [Abstract][Full Text] [Related]
6. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
7. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.
Beal MF; Ferrante RJ; Swartz KJ; Kowall NW
J Neurosci; 1991 Jun; 11(6):1649-59. PubMed ID: 1710657
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.
Brouillet E; Jenkins BG; Hyman BT; Ferrante RJ; Kowall NW; Srivastava R; Roy DS; Rosen BR; Beal MF
J Neurochem; 1993 Jan; 60(1):356-9. PubMed ID: 8417157
[TBL] [Abstract][Full Text] [Related]
9. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
[TBL] [Abstract][Full Text] [Related]
10. 3-Nitropropionic acid toxicity in the striatum.
Wüllner U; Young AB; Penney JB; Beal MF
J Neurochem; 1994 Nov; 63(5):1772-81. PubMed ID: 7523600
[TBL] [Abstract][Full Text] [Related]
11. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
12. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
[TBL] [Abstract][Full Text] [Related]
14. Extracellular perfusion of rat brain nuclei using microdialysis: a method for studying differential neurotransmitter release in response to neurotoxins.
Reynolds NC; Lin W; Cameron CM; Roerig DL
Brain Res Brain Res Protoc; 1999 Jul; 4(2):124-31. PubMed ID: 10446406
[TBL] [Abstract][Full Text] [Related]
15. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.
Brouillet E; Hantraye P; Ferrante RJ; Dolan R; Leroy-Willig A; Kowall NW; Beal MF
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7105-9. PubMed ID: 7624378
[TBL] [Abstract][Full Text] [Related]
16. Homocysteic acid lesions in rat striatum spare somatostatin-neuropeptide Y (NADPH-diaphorase) neurons.
Beal MF; Kowall NW; Swartz KJ; Ferrante RJ
Neurosci Lett; 1990 Jan; 108(1-2):36-42. PubMed ID: 1689475
[TBL] [Abstract][Full Text] [Related]
17. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
Araujo DM; Hilt DC
Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
[TBL] [Abstract][Full Text] [Related]
18. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid.
Nakao N; Brundin P
Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048
[TBL] [Abstract][Full Text] [Related]
20. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease.
Sun Z; Xie J; Reiner A
Exp Neurol; 2002 Jul; 176(1):55-65. PubMed ID: 12093082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
